Works matching Association for Molecular Pathology v. Myriad Genetics Inc.

Results: 62

ASSOCIATION FOR MOLECULAR PATHOLOGY V. MYRIAD GENETICS, INC: WHAT ARE THE EFFECTS ON CLONING EXTINCT ANIMALS AND AGRICULTURE NOW THAT CDNA IS PATENTABLE?

Published in:

Drake Journal of Agricultural Law, 2014, v. 19, n. 3, p. 347

By:

Slack, Chris

Publication type:

Article

ASSOCIATION FOR MOLECULAR PATHOLOGY v. MYRIAD GENETICS, INC.: PROGRESS BY PRINCIPLES.

Published in:

Journal of Health Care Law & Policy, 2015, v. 18, n. 1, p. 141

By:

BOLYARD, EMILY J.

Publication type:

Article

ROLLING WITH THE PUNCHES SINCE 1793: THE PATENT SYSTEM BEFORE AND AFTER ASSOCIATION FOR MOLECULAR PATHOLOGY V. MYRIAD GENETICS, INC., 133 S. CT. 2107 (2013).

Published in:

Southern Illinois University Law Journal, 2017, v. 41, n. 2, p. 305

By:

Sanges, Amber

Publication type:

Article

Association for Molecular Pathology v Myriad Genetics Inc: Are Genes Information or Molecules?

Published in:

Sydney Law Review, 2014, v. 36, n. 3, p. 557

By:

Orford, Jack

Publication type:

Article

PRODUCTOS DE LA NATURALEZA Y EL CASO ASSOCIATION FOR MOLECULAR PATHOLOGY V. MYRIAD GENETICS, INC.

Published in:

Propiedad Inmaterial, 2013, n. 17, p. 263

By:

CONDE-GUTIÉRREZ, CARLOS A.;
DÍAZ, LINA MARÍA

Publication type:

Article

AFTER PROMETHEUS, ARE HUMAN GENES PATENTABLE SUBJECT MATTER?

Published in:

Duke Law & Technology Review, 2013, v. 11, n. 2, p. 434

By:

ROGERS, DOUGLAS L.

Publication type:

Article

ASSOCIATION FOR MOLECULAR PATHOLOGY V. MYRIAD GENETICS, INC. AND ITS IMPACT ON THE PATENTABILTY OF "DESIGNER" GENES.

Published in:

Journal of Intellectual Property & Entertainment Law, 2014, v. 4, n. 1, p. 37

By:

RUSSO, AMANDA H.

Publication type:

Article

US Supreme Court's Decision on the Patent Ineligibility of Human Genes BRCA1/BRCA2 as Products of Nature.

Published in:

Journal of Commercial Biotechnology, 2015, v. 21, n. 4, p. 3, doi. 10.5912/jcb721

By:

Chakrabarty, Ananda M.

Publication type:

Article

Intellectual Property.

Published in:

Mercer Law Review, 2014, v. 65, n. 4, p. 1049

By:

Colton, Laurence P.

Publication type:

Article

LIFE, LIBERTY, AND THE PURSUIT OF GENETIC INFORMATION.

Published in:

Alabama Law Review, 2014, v. 65, n. 3, p. 625

By:

Kumar, Sapna

Publication type:

Article

THE SHAPE OF THINGS TO COME: A COHESIVE APPROACH TO PATENT-ELIGIBLE SUBJECT MATTER AND BIOTECHNOLOGY.

Published in:

Wake Forest Law Review, 2014, v. 49, n. 5, p. 1519

By:

Fowler, Karon

Publication type:

Article

ARE ALL GENES EQUAL?

Published in:

Journal of Science & Technology Law, 2014, v. 20, n. 1, p. 1

By:

GHOSH, SAMANTAK

Publication type:

Article

Genes, Patents, and the Supreme Court.

Published in:

Research Technology Management, 2013, v. 56, n. 6, p. 4

By:

Gwynne, Peter

Publication type:

Article

The Product of Nature Doctrine in the Myriad Saga II.

Published in:

European Journal of Risk Regulation, 2013, v. 4, n. 3, p. 409, doi. 10.1017/S1867299X00002725

By:

Gambini, Emanuela

Publication type:

Article

AFTER MYRIAD: RECONSIDERING THE INCENTIVES FOR INNOVATION IN THE BIOTECH INDUSTRY.

Published in:

Michigan Telecommunications & Technology Law Review, 2014, v. 21, n. 1, p. 141

By:

Yarbrough, Daniel K.

Publication type:

Article

THE MYRIAD REASONS TO HIT "RESET" ON PATENT-ELIGIBILITY JURISPRUDENCE.

Published in:

Loyola of Los Angeles Law Review, 2013, v. 47, n. 1, p. 117

By:

Heinrich, Alan J.;
Abernethy, Christopher T.

Publication type:

Article

STEMMING THE TIDE: STEM CELL INNOVATION IN THE MYRIAD-MAYO-ROSLIN ERA.

Published in:

Berkeley Technology Law Journal, 2015, v. 30, p. 567

By:

Hoxha, Eneda

Publication type:

Article

INTELLECTUAL PROPERTY.

Published in:

Bench & Bar of Minnesota, 2013, v. 70, n. 7, p. 39

By:

ZEULI, TONY;
VAUBEL, JOHN

Publication type:

Article

Mayo, Myriad, and a Muddled Analysis: Do Recent Changes to the Patentable Subject Matter Doctrine Threaten Patent Protections for Epigenetics-Based Inventions?

Published in:

Minnesota Law Review, 2018, v. 102, n. 5, p. 2229

By:

Sikora, Mike

Publication type:

Article

Patenting nature—a comparative perspective.

Published in:

Journal of Law & the Biosciences, 2018, v. 5, n. 3, p. 550, doi. 10.1093/jlb/lsy021

By:

Dreyfuss, Rochelle C;
Nielsen, Jane;
Nicol, Dianne

Publication type:

Article

VIROTECH PATENTS, VIROPIRACY, AND VIRAL SOVEREIGNTY.

Published in:

Arizona State Law Journal, 2013, v. 45, n. 4, p. 1563

By:

Yu, Peter K.

Publication type:

Article

The Supreme Court Renders a Decision on Gene Patents.

Published in:

Journal of the Association of Genetic Technologists, 2013, v. 39, n. 3, p. 107

By:

Sudduth, Kathy

Publication type:

Article

WHO DEFINES "HEALTHY"? ETHICAL DILEMMAS ACROSS COMPETING INTEREST GROUPS ON GENETIC MANIPULATION AND GENE PATENTS.

Published in:

DePaul Journal of Health Care Law, 2015, v. 17, n. 1, p. 47

By:

Guion, Haley

Publication type:

Article

A MYRIAD OF SOLUTIONS? A GUIDE FOR BIOTECH COMPANIES IN RESPONSE TO THE MYRIAD & MAYO DECISIONS.

Published in:

Elon Law Review, 2015, v. 7, n. 1, p. 431

By:

GENHEIMER, CHRISTOPHER W.

Publication type:

Article

PATENTABLE SUBJECT MATTER: A MYRIAD OF PROBLEMS.

Published in:

Alabama Law Review, 2014, v. 65, n. 3, p. 815

By:

Gipson, Jake

Publication type:

Article

THE CURRENT APPLICATION OF THE MYRIAD AND MAYO/ALICE RULINGS ON PATENT ELIGIBILITY: INCONSISTENT RESULTS AND CONTRADISTINGUISHING BIOTECHNOLOGY PRODUCTS.

Published in:

Cardozo Arts & Entertainment Law Journal, 2019, v. 38, n. 1, p. 183

By:

Cho, Skye

Publication type:

Article

A QUANTITATIVE APPROACH TO DETERMINING PATENTABLE SUBJECT MATTER.

Published in:

Harvard Journal of Law & Technology, 2017, v. 30, n. 2, p. 629

By:

Yuqing Cui

Publication type:

Article

PATENTING NATURAL PRODUCTS AFTER MYRIAD.

Published in:

Harvard Journal of Law & Technology, 2017, v. 30, n. 2, p. 569

By:

Tallmadge, Evan H.

Publication type:

Article

Morality: An Important Consideration at the Patent Office.

Published in:

California Law Review, 2020, v. 108, n. 1, p. 267, doi. 10.15779/Z38222R644

By:

Crockett, Julien

Publication type:

Article

Ruling to Overturn Human Gene Patents Is a Huge Win for Women's Health.

Published in:

GeneWatch, 2013, v. 26, n. 2/3, p. 7

By:

JAGGAR, KARUNA

Publication type:

Article

AMP v. Myriad: Preliminary Reflections.

Published in:

GeneWatch, 2013, v. 26, n. 2/3, p. 5

By:

SIMONCELLI, TANIA

Publication type:

Article

PATENTS AS DATA AGGREGATORS IN PERSONALIZED MEDICINE.

Published in:

2015

By:

BURK, DAN L.

Publication type:

Essay

TAKE OFF YOUR GENES AND LET THE DOCTOR HAVE A LOOK: WHY THE MAYO AND MYRIAD DECISIONS HAVE INVALIDATED METHOD CLAIMS FOR GENETIC DIAGNOSTIC TESTING.

Published in:

2013

By:

BERGIN, CHRISTOPHER

Publication type:

Opinion

Recent Pharmaceutical Patent Decisions in the United States.

Published in:

Journal of Intellectual Property Rights, 2014, v. 19, n. 1, p. 18

By:

Baltatzis, Andreas;
Marvin, Shoshana

Publication type:

Article

Federal Circuit Holds Isolated DNA Is Patent-Eligible - Association for Molecular Pathology v. United States Patent and Trademark Office (Myriad III).

Published in:

American Journal of Law & Medicine, 2012, v. 38, n. 4, p. 755, doi. 10.1017/s0098858800001027

By:

Cong Yao

Publication type:

Article

Patent Protection for Genetic Innovation: Monsanto and Myriad.

Published in:

Cato Supreme Court Review, 2012, p. 283

By:

Olson, David S.

Publication type:

Article

Patents at the Supreme Court: It Could've Been Worse.

Published in:

Cato Supreme Court Review, 2012, p. 267

By:

Dolin, Gregory

Publication type:

Article

GENE PATENTS IN THE WAKE OF ASSOCIATION FOR MOLECULAR PATHOLOGY V MYRIAD GENETICS, INC.: AN INTERNATIONAL PERSPECTIVE ON PHARMACOGENOMICS.

Published in:

Cardozo Journal of International & Comparative Law, 2014, v. 23, n. 1, p. 99

By:

S. Lim, Stephanie

Publication type:

Article

US Supreme Court addresses patent eligibility of isolated DNA and cDNA in Myriad V.

Published in:

Journal of Intellectual Property Law & Practice, 2013, v. 8, n. 11, p. 811, doi. 10.1093/jiplp/jpt156

By:

Macedo, Charles R.;
Goldberg, David P.

Publication type:

Article

ARIOSA DIAGNOSTICS V. SEQUENOM: METASTASIS OF MAYO AND MYRIAD AND THE EVISCERATION OF PATENT ELIGIBILITY FOR MOLECULAR DIAGNOSTICS.

Published in:

Berkeley Technology Law Journal, 2016, v. 31, p. 495, doi. 10.15779/Z38RG35

By:

Merksamer, Philip

Publication type:

Article

PATENTS WITHOUT TEETH: WHOLE GENOME SEQUENCING AND GENE PATENT INFRINGEMENT AFTER AMP v. MYRIAD.

Published in:

Jurimetrics: The Journal of Law, Science & Technology, 2013, v. 54, n. 1, p. 65

By:

Atkinson, Blake

Publication type:

Article

Applying Doctrine of Equivalents Tests to Products of Nature Decisions.

Published in:

Texas Intellectual Property Law Journal, 2016, v. 24, n. 2, p. 245

By:

Lesser, W.

Publication type:

Article

METAPHOR AFTER MYRIAD: THE EFFECT OF LEGAL RHETORIC ON INTELLECTUAL PROPERTY PROTECTION FOR BIOLOGICAL SEQUENCES.

Published in:

IDEA: The Intellectual Property Law Review, 2017, v. 57, n. 3, p. 519

By:

TSCHIDER, CHARLOTTE A.

Publication type:

Article

Patent Eligibility Post-Myriad: A Reinvigorated Judicial Wildcard of Uncertain Effect.

Published in:

2014

By:

Holman, Christopher M.

Publication type:

Essay

INCENTIVE FOR INNOVATION OR INVITATION TO INHUMANITY?: A HUMAN RIGHTS ANALYSIS OF GENE PATENTING AND THE CASE OF MYRIAD GENETICS.

Published in:

Utah Law Review, 2012, v. 2012, n. 1, p. 497

By:

Abbott, Laurie E.

Publication type:

Article

I'll Have Mayo With My Myriad: The Effect of Mayo Collaborative Services v. Prometheus Laboratories, Inc. and Association for Molecular Pathology v. U.S. Patent and Trademark Office on Patent Licensees and Licensors.

Published in:

Journal of Corporation Law, 2014, v. 39, n. 3, p. 639

By:

Forrest Vaubel, John

Publication type:

Article

Orphan Black, biocapital and venture science.

Published in:

Science Fiction Film & Television, 2018, v. 11, n. 3, p. 372, doi. 10.3828/sfftv.2018.24

By:

Vint, Sherryl

Publication type:

Article

Gene patents at the Supreme Court: Association for Molecular Pathology v. Myriad Genetics.

Published in:

Journal of Law & the Biosciences, 2014, v. 1, n. 2, p. 183, doi. 10.1093/jlb/lsu007

By:

Bakshi, Ashish M.

Publication type:

Article

What the Supreme Court's Myriad Decision Means for Nanotechnology Patents.

Published in:

Nanotechnology Law & Business, 2013, v. 10, p. 132

By:

Baluch, Andrew S.;
Maebius, Stephen B.;
Wegner, Harold C.

Publication type:

Article

The Patent Eligibility of Graphene Claims Following the U.S. Supreme Court's Myriad Decision.

Published in:

Nanotechnology Law & Business, 2013, v. 10, p. 123

By:

Terzoli Jr., Robert S.;
Gervasi, Christina N.;
Haag, Thomas

Publication type:

Article